(Q45044214)

reason for preferred rank

8 December 2017

title

Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain (English)

1 reference

https://api.crossref.org/works/10.1017/S0266462300005754

5 December 2022

Cost-benefit analysis of hepatitis-B vaccination. A computerized decision model for Spain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

main subject

cost–benefit analysis

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

viral hepatitis vaccines

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

mathematical model

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

biomedical technology assessment

5 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

1 reference

https://api.crossref.org/works/10.1017/S0266462300005754

5 December 2022

author name string

B. Jönsson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

B. Horisberger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

M. Bruguera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

L. Matter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834602

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1834602

5 December 2022

publication date

1 January 1991

1 reference

full work available at URL

8 December 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0266462300005754

1 reference

DOI

https://api.crossref.org/works/10.1017/S0266462300005754

International Journal of Technology Assessment in Health Care

5 December 2022

published in

1 reference

8 December 2017

volume

7

1 reference

8 December 2017

issue

3

1 reference

8 December 2017

page(s)

379-402

1 reference

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

How often does chronic liver disease follow acute hepatitis B in adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

Should all pregnant women be screened for hepatitis B?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

Exposure of the wound--a safe economy in the NHS

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

Measurement of health state utilities for economic appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

7 January 2021

Clinical aspects of delta infection

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

7 January 2021

Chronic evolution of acute hepatitis type B: prevalence and predictive markers

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

7 January 2021

Hepatitis B infection in a day school for mentally retarded students: transmission from students to staff

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

7 January 2021

Transfusion-associated hepatitis and AIDS. What is the risk?

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

7 January 2021

Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection

1 reference

https://api.crossref.org/works/10.1017%2FS0266462300005754

7 January 2021

Cost-benefit analysis of hepatitis-B vaccination

40

1 reference

DOI

https://api.crossref.org/works/10.1017/S0266462300005754

5 December 2022

Identifiers

DOI

1 reference

8 December 2017

1 reference